본문 바로가기
bar_progress

Text Size

Close

Huons Meditech Launches "Dermashine Pro" in Australia, Accelerates Academic Marketing

Huons Meditech Launches "Dermashine Pro" in Australia, Accelerates Academic Marketing Huons Meditech officials recently held a seminar in New South Wales, Australia, to announce the product launch. Photo by Huons Meditech

Huons Meditech, a medical device company under the Huons Group, has launched its electric drug infusion pump "Dermashine Pro" in Australia and has begun full-scale academic marketing activities.


On June 16, Huons Meditech announced that it had recently launched "Dermashine Pro" in Australia and participated in a launch seminar and a dermatology symposium.


The launch seminar was held on June 12 in Kingscliff, New South Wales. This event marked the first time Huons Meditech introduced "Dermashine Pro" in Oceania (Australia and New Zealand) together with its local distribution partner, SurgeMed.


Key opinion leaders (KOLs) from Korea and abroad attended as speakers and introduced the "Dermashine Pro" procedure to approximately 200 local medical professionals. In particular, Choi Hosung, Director of Piona Clinic, gave an on-site explanation and demonstration of "Dermashine Pro," attracting significant attention.


From June 13 to 15, Huons Meditech also participated in the Non-Surgical Symposium (NSS) held in Gold Coast, Queensland, where it showcased "Dermashine Pro." Now in its 14th year, NSS is the largest global non-surgical aesthetic symposium in Australia. At the event, Huons Meditech, together with local KOLs, presented live procedure demonstrations and clinical application cases of "Dermashine Pro."


"Dermashine Pro" is a dermatology medical device equipped with precise drug infusion capabilities and a user-centered interface. Huons Meditech has obtained certification for "Dermashine Pro" from the Australian Therapeutic Goods Administration (TGA). Based on this, the company plans to carry out aggressive marketing in the Australian market and accelerate its entry into the global aesthetics market.


Lee Jinseok, CEO of Huons Meditech, stated, "With the high preference for Korean aesthetics in Australia and New Zealand, we signed a product distribution agreement earlier this year and have now successfully held the launch seminar. Moving forward, we will actively participate in overseas exhibitions and academic conferences to increase our brand awareness in the global market."


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top